Neuropeptide Y attenuates atress-induced bone loss through suppression of noradrenaline circuits.
Chronic stress and depression have adverse consequences on many organ systems; including the skeleton, but the mechanisms underlying the stress-induced bone loss remain unclear. Here we demonstrate that neuropeptide Y (NPY), centrally and peripherally, plays a critical role in protecting against stress-induced bone loss. Mice lacking the anxiolytic factor NPY exhibit more anxious behavior and elevated corticosterone levels. Additionally, following a 6 week restraint, or cold stress-protocol, Npy null mice exhibit 3-fold greater bone loss compared to wild type, due to suppression of osteoblast activity. This stress-protective NPY pathway acts specifically through Y2 receptors. Centrally, Y2 receptors suppress corticotropin-releasing factor expression and inhibit activation of noradrenergic neurons in the paraventricular nucleus. In the periphery, they act to control noradrenaline release from sympathetic neurons. Specific deletion of arcuate Y2 receptors recapitulates the Npy null stress response, coincident with elevated serum noradrenaline. Importantly, specific re-introduction of NPY solely in noradrenergic neurons of otherwise Npy null mice, blocks the increase in circulating noradrenaline and the stress-induced bone loss. Thus, NPY protects against excessive stress-induced bone loss, through Y2 receptor-mediated modulation of central and peripheral noradrenergic neurons.
|Authors||Baldock, P.; Lin, S.; Zhang, L.; Karl, T.; Shi, Y.; Driessler, F.; Zengin, A. Hormer, B.; Lee, N.; Wong, I.; Lin, E.; Enriquez, R.; Stehrer, B.; During, M.; Yulyaningsih, E.; Zolotukhin, S.; Ruohonen, S.; Savontaus, E.; Sainsbury, A.; Herzog, H.|
|Publisher Name||JOURNAL OF BONE AND MINERAL RESEARCH|
|URL link to publisher's version||http://www.ncbi.nlm.nih.gov/pubmed/24535841|
|OpenAccess link to author's accepted manuscript version||https://publications.gimr.garvan.org.au/open-access/12116|